naltrexone has been researched along with Depressive Disorder in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 9 (33.33) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 10 (37.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JC; Takayesu, AG | 1 |
| Bidlack, JM; Callaghan, CK; Dean, RL; Deaver, DR; Knapp, BI; O'Mara, SM; Rouine, J | 1 |
| da Luz, SC; Nogueira, CW; Pesarico, AP; Rosa, SG; Tagliapietra, CF | 1 |
| Gregg, M; Martinez, L; Samaritan, G | 1 |
| Babb, SM; Cohen, BM; Murphy, BL; Ravichandran, C | 1 |
| Hang, A; Liu, JG; Liu, Y; Shu, XH; Wang, Q; Wang, YJ; Zan, GY | 1 |
| Gofman, AG; Ponizovskiy, PA | 1 |
| Rahman, S | 1 |
| Johnson, BA | 1 |
| Belkız Güngör, B; Çetinay Aydın, P; Gülseren, L | 1 |
| Bell, JR; Haber, PS; Morley, KC; Phung, N; Reid, SC; Richardson, K; Sannibale, C; Teesson, M; Thomson, C; Weltman, M | 1 |
| Bakharev, VD; Tikhomirov, SM | 1 |
| Volavka, J | 1 |
| Buchsbaum, MS; Davis, GC | 1 |
| Crits-Christoph, K; Kleber, H; Rounsaville, BJ; Weissman, MM; Wilber, C | 1 |
| Mason, BJ | 1 |
| Calandra, C; Marchetti, B; Parrinello, MA; Scifo, R | 1 |
| Barocka, A; Kaschka, WP; Plaskacewicz, GJ; Rechlin, T; Wildt, L; Zimmermann, U | 1 |
| Frosch, D; Ling, W; McCann, MJ; Miotto, K; Rawson, RA | 1 |
| Cornelius, JR; Daley, DC; Kirisci, L; Salloum, IM; Spotts, C; Thase, ME | 1 |
| Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM | 1 |
| Neumeister, A; Winkler, A; Wöber-Bingöl, C | 1 |
| Amiaz, R; Dannon, PN; Grunhaus, L; Schreiber, S; Stein, O | 1 |
| Farren, CK; O'Malley, SS | 1 |
| Cornelius, JD; Salloum, IM; Thase, ME | 1 |
| Ritter, AJ | 1 |
| Lienemann, J; Walker, FD | 1 |
7 review(s) available for naltrexone and Depressive Disorder
| Article | Year |
|---|---|
[Depression in alcohol addicted patients].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Taurine | 2015 |
Medication treatment of different types of alcoholism.
Topics: Adult; Aged; Alcohol Deterrents; Alcoholism; Baclofen; Chronic Disease; Depressive Disorder; Female; Fructose; Humans; Hypothalamo-Hypophyseal System; Limbic System; Male; Naltrexone; Ondansetron; Pituitary-Adrenal System; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, GABA; Topiramate; Young Adult | 2010 |
[Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Mental Disorders; Naloxone; Naltrexone; Nerve Tissue Proteins; Pituitary Hormones; Psychotropic Drugs; Schizophrenia; Substance-Related Disorders; Vasopressins | 1984 |
Dosing issues in the pharmacotherapy of alcoholism.
Topics: Administration, Oral; Adult; Alcoholism; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Imipramine; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic | 1996 |
Anxiolytics, adrenergic agents, and naltrexone.
Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1999 |
Comorbid alcoholism and depression: treatment issues.
Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Counseling; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose.
Topics: Depressive Disorder; Drug Overdose; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Risk Factors | 2002 |
6 trial(s) available for naltrexone and Depressive Disorder
| Article | Year |
|---|---|
Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Young Adult | 2014 |
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety; Australia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Secondary Prevention; Taurine; Treatment Outcome | 2006 |
Action of naloxone and naltrexone in different types of psychoses.
Topics: Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Endorphins; Humans; Naloxone; Naltrexone; Psychotic Disorders; Receptors, Opioid; Schizophrenia | 1981 |
Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study.
Topics: Adult; Antidepressive Agents, Tricyclic; Appetite; Depressive Disorder; Female; Humans; Lithium; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Weight Gain | 1997 |
Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts.
Topics: Adult; Depressive Disorder; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Psychiatric Status Rating Scales; Psychotherapy; Suicide, Attempted | 1997 |
Naltrexone utility in depressed alcoholics.
Topics: Adult; Alcoholism; Depressive Disorder; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Pilot Projects | 1998 |
14 other study(ies) available for naltrexone and Depressive Disorder
| Article | Year |
|---|---|
Gambling Disorder and Concurrent Alcohol Use Disorder Treated With Naltrexone.
Topics: Adult; Alcoholism; Depressive Disorder; Gambling; Humans; Male; Naltrexone; Narcotic Antagonists | 2017 |
Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cell Proliferation; Depression; Depressive Disorder; Disease Models, Animal; Hippocampus; Interferon-alpha; Male; Naltrexone; Narcotic Antagonists; Neurons; Rats, Wistar; Receptors, Opioid | 2018 |
Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Organosilicon Compounds; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Swimming | 2017 |
Informed consent abandoned--patient given contraindicated drug.
Topics: Alcoholism; Contraindications; Depressive Disorder; Humans; Informed Consent; Male; Medication Reconciliation; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Risk Management; Treatment Outcome | 2014 |
Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Enkephalins; Male; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Protein Precursors; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome | 2015 |
Targeting opioid receptors: A new treatment for brain disorders.
Topics: Animals; Antidepressive Agents; Anxiety Disorders; Brain; Depressive Disorder; Disease Models, Animal; Humans; Limbic System; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WKY; Receptors, Opioid, kappa | 2010 |
Naltrexone treatment of kleptomania: a case report.
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluoxetine; Humans; Naltrexone; Obsessive-Compulsive Disorder | 2012 |
Pain sensitivity and endorphins in functional psychoses.
Topics: Bipolar Disorder; Depressive Disorder; Endorphins; Evoked Potentials, Somatosensory; Female; Humans; Male; Naltrexone; Nociceptors; Pain; Psychotic Disorders; Receptors, Opioid; Schizophrenic Psychology; Sensory Thresholds | 1981 |
Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.
Topics: Adult; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Therapeutic Community | 1982 |
Prognostic significance of depression occurrence in infantile autism.
Topics: Adolescent; Antidepressive Agents; Autistic Disorder; Child; Depressive Disorder; Humans; Male; Naltrexone; Prognosis | 1996 |
Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
Topics: Adolescent; Bulimia; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 1999 |
Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine--a case report.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Paroxetine | 1999 |
Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine | 1999 |
Reversal of self-abusive behavior with naltrexone.
Topics: Depressive Disorder; Female; Humans; Middle Aged; Naltrexone; Self Mutilation | 1989 |